Alex Carignan

Alex Carignan

Sherbrooke, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections: A Secondary Analysis of the BALANCE Trial.

Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections: A Secondary Analysis of the BALANCE Trial.

Journal: JAMA network open
Published: June 29, 2026

Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network study.

Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network study.

Journal: Human vaccines & immunotherapeutics
Published: March 18, 2026

Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trial.

Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trial.

Journal: Trials
Published: November 06, 2025

In hospitalized patients with bacteremia, is a 7-day antibiotic treatment noninferior to a 14-day treatment with respect to mortality?

In hospitalized patients with bacteremia, is a 7-day antibiotic treatment noninferior to a 14-day treatment with respect to mortality?

Journal: La Revue de medecine interne
Published: January 29, 2025

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections.

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections.

Journal: The New England journal of medicine
Published: November 20, 2024

Neurological adverse events following COVID-19 vaccination among Canadians referred to the special immunization clinic network.

Neurological adverse events following COVID-19 vaccination among Canadians referred to the special immunization clinic network.

Journal: Vaccine
Published: September 23, 2024

Current and future burden from Lyme disease in Québec as a result of climate change.

Current and future burden from Lyme disease in Québec as a result of climate change.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada
Published: March 14, 2024

Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study.

Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study.

Journal: Vaccine
Published: February 22, 2024

The safety of seasonal influenza vaccination among adults prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data.

The safety of seasonal influenza vaccination among adults prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data.

Journal: Vaccine
Published: August 29, 2023

Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.

Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.

Journal: JAMA network open
Published: October 14, 2022

Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial.

Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial.

Journal: BMJ open
Published: July 21, 2022

Management and clinical outcomes of Lyme disease in acute care facilities in 2 endemic regions of Quebec, Canada: a multicentre retrospective cohort study.

Management and clinical outcomes of Lyme disease in acute care facilities in 2 endemic regions of Quebec, Canada: a multicentre retrospective cohort study.

Journal: CMAJ open
Published: June 28, 2022
Showing 1-12 of 55

Last Updated: 09/26/2026